Skip to main content
Clinical Trials/NCT03355521
NCT03355521
Completed
Not Applicable

Effects of Nordic Walking Training on Functional, Clinical and Biomechanics Parameters in Parkinson's Disease: a Randomized Controlled Clinical Trial

Federal University of Rio Grande do Sul1 site in 1 country33 target enrollmentMarch 20, 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Federal University of Rio Grande do Sul
Enrollment
33
Locations
1
Primary Endpoint
Test Timed Up and Go
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The aim of this study was to evaluate and compare the effects of a Nordic and free walking training program on clinical, functional and biomechanical parameters of gait, in people with PD.

Outcomes: Motor symptoms: Staging and severity of PD, balance, walking functional mobility, self-selected walking velocity, and rehabilitation index. Non-Motor symptoms: Cognitive function, depressive symptoms, and quality of life (QL). Outcomes Biomechanics: Kinematic parameters (spatiotemporal and dynamic stability of walking) and neuromuscular parameters (amplitude of the electromyography signal, initial and final activation threshold, activation time and co-contraction index, of the following muscles: Vastus Lateralis (VL), Biceps Femoris (BF), Tibialis Anterior (TA), Gastrocnemius Medialis (GM).

Detailed Description

Introduction: Changes in clinical, functional and biomechanical parameters of gait are remarkable features in Parkinson's disease (PD). Such changes are disabling for the performance of daily living activities (DLAs) as they represent a high risk of falls and impair quality of life (QL) in this population. Although exercise is recommended as an effective model of therapeutic intervention, to minimize the symptoms of this disease, little is known about the effects of Nordic walking on motor and non-motor symptoms in patients with PD. Purpose: The aim of this study was to evaluate and compare the effects of a Nordic and free walking training program on clinical, functional and biomechanical parameters of gait, in people with PD. Experimental Design: Randomized controlled clinical trial (RCT). Study Site: Physical Education School of the Federal University of Rio Grande do Sul and the Clinical Hospital of Porto Alegre, in Porto Alegre, Rio Grande do Sul, Brazil. Methods: The sample comprised 33 participants, aged above 50 years, of both sexes, with a clinical diagnosis of idiopathic PD, with the staging of 1-4 in the Hoehn and Yahr scale (H\&Y). The participants received two types of intervention: Nordic walking training program (NW, n = 16) and free walking training program (FW, n = 17), during six weeks. Aiming to evaluate the effects of the training program, the participants underwent the tests in the following period: pre-training + pre-familiarization (T1); post-familiarization + pre-training (T2); post-training (T3).

Registry
clinicaltrials.gov
Start Date
March 20, 2013
End Date
July 30, 2014
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of Rio Grande do Sul
Responsible Party
Principal Investigator
Principal Investigator

Leonardo A. Peyré-Tartaruga

Adjunct Professor

Federal University of Rio Grande do Sul

Eligibility Criteria

Inclusion Criteria

  • volunteers aged over 50 years, of both sexes, with a clinical diagnosis of idiopathic PD and staging between 1 and 4 in Hoehn and Yahr Scale (H\&Y).

Exclusion Criteria

  • Show chronic pain or presence of a migraine or nausea in daily life;
  • History of labyrinthitis;
  • Deep Brain Stimulation (DBS);
  • The frequency of training below of 75%.

Outcomes

Primary Outcomes

Test Timed Up and Go

Time Frame: Change from baseline at 9 weeks

This teste evaluate the mobility functional in three meters of self-selected speed (TUGSS) or at forced speed (TUGFS)

Secondary Outcomes

  • Locomotor Rehabilitation Index(Change from baseline at 9 weeks)
  • Self-selected walking speed - SSWS(Change from baseline at 9 weeks)
  • Optimal Walking Speed (OPT)(Change from baseline at 9 weeks)
  • Quality of life (QoL)(Change from baseline at 9 weeks)
  • Cognitive function(Change from baseline at 9 weeks)
  • Depressive symptoms(Change from baseline at 9 weeks)

Study Sites (1)

Loading locations...

Similar Trials